Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
ZimVie Inc.
13G/A
ZIMV · 98888T107
|
0% |
8/27/2025
Event 7/21/2025
|
|||
| Camber Capital Management LP | 0% | ||||
| Stephen DuBois | 0% | ||||
|
Brookdale Senior Living Inc.
13G/A
BKD · 112463104
|
2.7% |
5/16/2025
Event 3/31/2025
|
|||
| Camber Capital Management LP | 2.7% | ||||
| Stephen DuBois | 2.7% | ||||
|
Orasure Technologies Inc
13G/A
OSUR · 68554V108
|
1.2% |
5/15/2025
Event 3/31/2025
|
|||
| Camber Capital Management LP | 1.2% | ||||
| Stephen DuBois | 1.2% | ||||
|
Inogen Inc
13G/A
INGN · 45780L104
|
3.7% |
5/15/2025
Event 3/31/2025
|
|||
| Camber Capital Management LP | 3.7% | ||||
| Stephen DuBois | 3.7% | ||||
|
PTC Therapeutics, Inc.
13G/A
PTCT · 69366J200
|
4.2% |
2/14/2025
Event 12/31/2024
|
|||
| Camber Capital Management LP | 4.2% | ||||
| Stephen DuBois | 4.2% | ||||
|
Puma Biotechnology, Inc.
13G/A
PBYI · 74587V107
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Camber Capital Management LP | 0% | ||||
| Stephen DuBois | 0% | ||||
|
Myriad Genetics Inc
13G/A
MYGN · 62855J104
|
3.4% |
2/14/2025
Event 12/31/2024
|
|||
| Camber Capital Management LP | 3.4% | ||||
| Stephen DuBois | 3.4% | ||||
|
Solid Biosciences Inc.
13G/A
SLDB · 83422E105
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Camber Capital Management LP | 0% | ||||
| Stephen DuBois | 0% | ||||